NCT01139268

Brief Summary

Infertility affects an increasing number of couples. For many, the choice of treatment is in vitro fertilization (IVF) . Currently, there are no markers fully predictive of developmental competence of IVF embryos. Present embryo selection is based on morphology assessment, which produces implantation rates in the range of 20%-30 %. The overall purpose of the present study is to investigate methods for selection of the best embryo. We aim to examine the relationship between pregnancy outcome and the transcriptional profile of selected genes, cleavage kinetics (time-lapse), and metabolic profile. We hypothesise that the quality of the embryo is reflected by the transcription of selected genes, the cleavage kinetics, and the metabolic profile. If so, these parameters can predict the success or failure of a pregnancy. Furthermore, the interrelationship - if any - between these parameters will be evaluated. A secondary aim is to evaluate the effect of blastomere biopsy using time-lapse and metabolic analysis

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
161

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2010

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2010

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

June 7, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 8, 2010

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

July 18, 2013

Status Verified

July 1, 2013

Enrollment Period

3 years

First QC Date

June 7, 2010

Last Update Submit

July 17, 2013

Conditions

Keywords

embryo viability

Outcome Measures

Primary Outcomes (1)

  • implantation/clinical pregnancy confirmed with pregnancy test and ultrasound

    measurement of urine-hCG and vaginal ultrasound scan to evaluate pregnant/not pregnant

    8 weeks after embryo transfer

Secondary Outcomes (3)

  • gene expression quantified with Q-PCR

    within 6 months after biopsy and embryo transfer

  • Metabolic profile using NIR analysis

    within 6 months after collection

  • cleavage kinetics

    before embryo transfer, during culturing

Eligibility Criteria

Age18 Years - 37 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women undergoing ART treament with single embryo transfer at the Fertility clinic, Aarhus University hospital Skejby, due to infertility,

You may qualify if:

  • age \< 38 years
  • \> 8 retrieved oocytes in present cycle or \> 6 fertilized.

You may not qualify if:

  • endometriosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Fertility Clinic, Aarhus University Hospital, Skejby

Aarhus, 8200, Denmark

Location

Fertility Clinic, Aarhus University Hospital Skejby

Aarhus N, 8200, Denmark

Location

Related Publications (5)

  • Kirkegaard K, Svane AS, Nielsen JS, Hindkjaer JJ, Nielsen NC, Ingerslev HJ. Nuclear magnetic resonance metabolomic profiling of Day 3 and 5 embryo culture medium does not predict pregnancy outcome in good prognosis patients: a prospective cohort study on single transferred embryos. Hum Reprod. 2014 Nov;29(11):2413-20. doi: 10.1093/humrep/deu236. Epub 2014 Sep 24.

  • Sundvall L, Ingerslev HJ, Breth Knudsen U, Kirkegaard K. Inter- and intra-observer variability of time-lapse annotations. Hum Reprod. 2013 Dec;28(12):3215-21. doi: 10.1093/humrep/det366. Epub 2013 Sep 26.

  • Kirkegaard K, Hindkjaer JJ, Ingerslev HJ. Hatching of in vitro fertilized human embryos is influenced by fertilization method. Fertil Steril. 2013 Nov;100(5):1277-82. doi: 10.1016/j.fertnstert.2013.07.005. Epub 2013 Jul 30.

  • Kirkegaard K, Kesmodel US, Hindkjaer JJ, Ingerslev HJ. Time-lapse parameters as predictors of blastocyst development and pregnancy outcome in embryos from good prognosis patients: a prospective cohort study. Hum Reprod. 2013 Oct;28(10):2643-51. doi: 10.1093/humrep/det300. Epub 2013 Jul 30.

  • Kirkegaard K, Hindkjaer JJ, Ingerslev HJ. Effect of oxygen concentration on human embryo development evaluated by time-lapse monitoring. Fertil Steril. 2013 Mar 1;99(3):738-744.e4. doi: 10.1016/j.fertnstert.2012.11.028. Epub 2012 Dec 11.

Biospecimen

Retention: SAMPLES WITH DNA

biopsies from human embryos

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Jakob Ingerslev, MD, DMsc

    Fertility Clinic, Aarhus University Hospital, Skejby

    STUDY DIRECTOR
  • kirstine Kirkegaard, MD

    Fertility Clinic, Aarhus University Hospital, Skejby

    PRINCIPAL INVESTIGATOR
  • Johnny Hindkjær, DM.Sc.

    Fertility Clinic, Aarhus University Hospital, Skejby

    PRINCIPAL INVESTIGATOR
  • Birte Degn, DmSc. PhD

    Fertility Clinic, Aarhus University Hospital, Skejby

    PRINCIPAL INVESTIGATOR
  • Karin Lykke-Hartmann, DmSc, PhD

    Aarhus University, Department of Medical Biochemistry

    PRINCIPAL INVESTIGATOR
  • Steen Koelvraa, MD, DMSc

    Department of Clinical Genetics, Vejle Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2010

First Posted

June 8, 2010

Study Start

June 1, 2010

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

July 18, 2013

Record last verified: 2013-07

Locations